Subacute and chronic prurigo effectively treated with recombinant interferon-γ: Implications for participation of Th2 cells in the pathogenesis of prurigo

Acta Dermato-Venereologica

Volumn 77, Issue 3, 1997, Pages 231-234

  Tokura, Yoshiki ^a   Yagi, Hiroaki ^a   Hanaoka, Kotaro ^a   Ito, Taisuke ^a   Towyama, Kyoko ^a   Sachi, Yoshifumi ^b   Tanaka, Masato ^c   Sakamoto, Taiko ^c   Sekizuka, Toshiyuki ^a   Furukawa, Fukumi ^a   Takigawa, Masahiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hamaoka Municipal Hospital   (Japan)

^c FUJIEDA MUNICIPAL GENERAL HOSPITAL   (Japan)

Author keywords

cytokine; T lymphocytes; therapy

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; PSORALEN; RECOMBINANT GAMMA INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; DRUG EFFICACY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; MONONUCLEAR CELL; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PRIORITY JOURNAL; PRURIGO; PUVA; RNA ANALYSIS; SKIN BIOPSY; TOPICAL DRUG ADMINISTRATION;

ADULT; AGED; CHRONIC DISEASE; DERMATOLOGIC AGENTS; HUMANS; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKINS; MIDDLE AGED; PRURIGO; TH2 CELLS;

EID: 8244243940     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Jorizzo JL, Gatti S, Smith EB. Prurigo: a clinical review. J Am Acad Dermatol 1981; 4: 723-728.
2. Griether A. On the different forms of prurigo: pruritus-prurigo. Curr Probl Dermatol 1970; 3: 1-30.
3. Burton JL. Prurigo. In: Champion RH, Burton JL, Ebling FJG, eds. Textbook of dermatology. Oxford: Blackwell Scientific Publications, 1992: 581-584.
4. Uehara M, Ofuji S. Primary eruption of prurigo simplex subacuta. Dermatologica 1976; 153: 49-56.
5. Mali JWH. Prurigo simplex subacuta: a group of cases with atopic background. Acta Derm Venereol (Stockh) 1967; 47: 304-308.
6. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989; 7: 145-173.
7. Romagnani S. Human Th1 and Th2 subsets: doubt no more, Immunol Today 1991; 12: 256-257.
8. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994; 76: 241-251.
9. Yagi H, Tokura Y, Furukawa F, Takigawa M. CD7-positive Sézary syndrome with a Th1 cytokine profile. J Am Acad Dermatol 1996; 34: 368-374.
10. Yagi H, Tokura Y, Furukawa F, Takigawa M. Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-γ. J Invest Dermatol 1996; 107: 829-832.
11. Fushimi M, Tokura Y, Sachi Y, Hashizume H, Sudo H, Wakita H, et al. Eosinophilic pustular folliculitis effectively treated with recombinant interferon-γ: suppression of mRNA expression of interleukin 5 in peripheral blood mononuclear cells. Br J Dermatol 1996; 134: 766-772.
12. Boguniewicz M, Jaffe HS, Izu A, Sullivan MJ, York D, Geha RS, et al. Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels. Am J Med 1990; 88: 365-370.
13. Jung T, Lack G, Schauer U, Überück W, Renz H, Gelfand EW, et al. Decreased frequency of interferon-γ- and interleukin-2-producing cells in patients with atopic diseases measured at the single cell level. J Allergy Clin Immunol 1995; 96: 515-527.
14. Tanaka M, Aiba S, Matsumura N, Aoyama H, Tagami H. Prurigo nodularis consists of two distinct forms: early-onset atopic and late-onset non-atopic. Dermatology 1995; 190: 269-276.